These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33369192)

  • 1. CaMKIIγ regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-κB pathway.
    Cheng JH; Zhang WJ; Zhu JF; Cui D; Song KD; Qiang P; Mei CZ; Nie ZC; Ding BS; Han Z; Ding ZE; Zheng WW
    Int J Lab Hematol; 2021 Aug; 43(4):699-706. PubMed ID: 33369192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
    Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H
    RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
    Li Z; Wang F; Tian X; Long J; Ling B; Zhang W; Xu J; Liang A
    J Exp Clin Cancer Res; 2021 Jun; 40(1):210. PubMed ID: 34167558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CaMKIIγ promotes in vitro and in vivo growth of colorectal cancer cells by upregulating nuclear factor-κB signaling pathway].
    Xu F; Qi H; Yu X; Xu R
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):649-53. PubMed ID: 23688981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
    Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
    Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis.
    Gu Y; Zheng W; Zhang J; Gan X; Ma X; Meng Z; Chen T; Lu X; Wu Z; Huang W; Xu R
    Leukemia; 2016 Jun; 30(6):1282-9. PubMed ID: 27012864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic Injury-Induced CaMKIIδ and CaMKIIγ Confer Neuroprotection Through the NF-κB Signaling Pathway.
    Ye J; Das S; Roy A; Wei W; Huang H; Lorenz-Guertin JM; Xu Q; Jacob TC; Wang B; Sun D; Wang QJ
    Mol Neurobiol; 2019 Mar; 56(3):2123-2136. PubMed ID: 29992531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell dissection reveals promotive role of ENO1 in leukemia stem cell self-renewal and chemoresistance in acute myeloid leukemia.
    Tian Y; Guo J; Mao L; Chen Z; Zhang X; Li Y; Zhang Y; Zha X; Luo OJ
    Stem Cell Res Ther; 2024 Oct; 15(1):347. PubMed ID: 39380054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TAK1-NF-κB axis as therapeutic target for AML.
    Bosman MC; Schepers H; Jaques J; Brouwers-Vos AZ; Quax WJ; Schuringa JJ; Vellenga E
    Blood; 2014 Nov; 124(20):3130-40. PubMed ID: 25287709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia.
    Stranahan AW; Berezniuk I; Chakraborty S; Feller F; Khalaj M; Park CY
    Leukemia; 2022 Jun; 36(6):1575-1584. PubMed ID: 35461365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.
    Wang Y; Skibbe JR; Hu C; Dong L; Ferchen K; Su R; Li C; Huang H; Weng H; Huang H; Qin X; Jin J; Chen J; Jiang X
    Sci Rep; 2017 May; 7(1):1853. PubMed ID: 28500307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
    Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
    Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34
    Murone M; Radpour R; Attinger A; Chessex AV; Huguenin AL; Schürch CM; Banz Y; Sengupta S; Aguet M; Rigotti S; Bachhav Y; Massière F; Ramachandra M; McAllister A; Riether C
    Mol Cancer Ther; 2017 Aug; 16(8):1497-1510. PubMed ID: 28468777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress.
    Costa RGA; Oliveira MS; Rodrigues ACBDC; Silva SLR; Dias IRSB; Soares MBP; de Faro Valverde L; Gurgel Rocha CA; Dias RB; Bezerra DP
    J Cell Mol Med; 2024 Apr; 28(8):e18333. PubMed ID: 38652192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.
    Quotti Tubi L; Canovas Nunes S; Brancalion A; Doriguzzi Breatta E; Manni S; Mandato E; Zaffino F; Macaccaro P; Carrino M; Gianesin K; Trentin L; Binotto G; Zambello R; Semenzato G; Gurrieri C; Piazza F
    Leukemia; 2017 Feb; 31(2):292-300. PubMed ID: 27479180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
    Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.